Drug manufacturer Moderna’s vaccine against the coronavirus will be priced between $25 (approximately Rs 1,854) and $37 (approximately Rs ...
Drug manufacturer Moderna’s vaccine against the coronavirus will be priced between $25 (approximately Rs 1,854) and $37 (approximately Rs 2,744) per dose, depending on the amount ordered by governments, company’s Chief Executive Officer Stephane Bancel said, Reuters reported on Sunday.
The vaccine candidate was found to be 94.5% effective against the virus during its phase three trials.
“Our vaccine therefore costs about the same as a flu shot, which is between $10 and $50,” Bancel told told German weekly, Welt am Sonntag, according to the news agency.
This came a day after an unidentified official of the European Union told Reuters that the European Commission wants to reach a deal with Moderna for the supply of millions of doses of its COVID-19 vaccine candidate for a price below $25 per dose.
Countries such as Britain, the US, France and Germany have been widely criticised for directly negotiating deals with pharmaceutical companies to receive billions of doses, meaning a majority of the world’s vaccine supply next year is already reserved.
Bancel said that no deal had been signed between Moderna and the countries so far. “But we are close to a deal with the EU Commission,” he said, adding that it was just a “matter of days” until a contract would be ready. “We want to deliver to Europe and are...
